Exelixis
EXEL
$21.69
Share price
4.38%
Change (1 day)
11.86%
Change (1 year)
Categories
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.
Stock price history for Exelixis (EXEL)
Highest end of day price: $49.25 USD on 2000-07-26
Lowest end of day price: $1.29 USD on 2014-12-24
Stock price history of Exelixis from 2000 to 2024
Stock price for similar companies or competitors
| Company | Stock price | Change 1d% | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $146.67 | 0.96% | 🇺🇸 USA |
 Pfizer PFE | $28.66 | 1.63% | 🇺🇸 USA |
 Amgen AMGN | $305.85 | 1.61% | 🇺🇸 USA |
 Sanofi SNY | $49.03 | 2.51% | 🇫🇷 France |
 Merck MRK | $125.54 | 0.81% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $41.09 | 2.09% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $44.77 | 1.70% | 🇬🇧 UK |
 Curis CRIS | $10.36 | -2.54% | 🇺🇸 USA |
 AVEO Oncology
AVEO | $15.00 | 0.00% | 🇺🇸 USA |